Skadden is representing Human Genome Sciences, Inc. in its $3.6 billion acquisition by GlaxoSmithKline plc, announced on July 16.
GSK to Acquire Human Genome Sciences
Skadden is representing Human Genome Sciences, Inc. in its $3.6 billion acquisition by GlaxoSmithKline plc, announced on July 16.